Colgate-Palmolive (NYSE: CL) reported Q3 EPS of $0.81, $0.02 better than the analyst estimate of $0.79. Revenue for the quarter came in at $4.41 billion versus the consensus estimate of $4.4 billion.

Full Year 2021 Guidance:

Based on current spot rates:

• The Company expects net sales to be up 4% to 7% including a low-single-digit benefit from foreign exchange.
• The Company expects organic sales to be up within its long-term targeted range of 3% to 5%.
• On a GAAP basis, the Company expects a decline in gross profit margin, increased advertising investment and earnings-per-share growth at the lower end of its low to mid-single-digit range.
• On a non-GAAP (Base Business) basis, the Company expects a decline in gross profit margin, increased advertising investment and earnings-per-share growth at the lower end of its mid to high-single-digit range.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.